As senior vice president of cancer care, Timothy Seay-Morrison, EdD, leads strategy and operations for one of Palo Alto, Calif.-based Stanford Health Care’s largest service lines. Part of Stanford (Calif.) Medicine, Stanford Health Care is a nonprofit academic medical system…
Oncology
Geographic and racial disparities in late-stage breast cancer diagnoses persist among rural patients, a population already at elevated risk for advanced disease, according to a study published March 11 in the Journal of the American College of Surgeons. Researchers at…
Mary Bird Perkins Cancer Center and Louisiana State University, both based in Baton Rouge, have appointed Kenneth Matthews, PhD, as director of the Dr. Charles M. Smith Medical and Health Physics Program. Dr. Matthews previously served as interim program director…
Boston-based Dana-Farber Cancer Institute recorded an operating income of $91.5 million (8.4% operating margin) in the first quarter of 2026, up from $69.1 million (7% margin) during the same period last year, according to its March 11 financial report. Dana-Farber…
Somerville, Mass.-based Mass General Brigham has received $50 million from anonymous donors to fuel cancer research efforts. The donors said the gift was made “with deep gratitude for the compassionate and expert care provided by staff across Mass General Brigham,”…
Advertisement
Hospital utilization of oncology biosimilars — and the price markup margins associated with them — have increased, according to a study published March 11 in JAMA. Researchers from University of California Berkeley and Providence, R.I.-based Brown University analyzed Blue Cross…
Oklahoma City-based Oklahoma Children’s Hospital has become the first facility in Oklahoma to offer a targeted chemotherapy treatment for retinoblastoma, according to a March 9 report KOCO News. The treatment delivers chemotherapy directly to the patient’s eye via catheter, bypassing…
Seattle-based Fred Hutch Cancer Center has appointed Mazyar Shadman, MD, and Vyshak Alva Venur, MD, as deputy chief medical officers. Both have served as interim deputy chief medical officers since September, according to a March 10 LinkedIn post from the…
The FDA has approved a new device to treat adults with locally advanced pancreatic cancer in combination with gemcitabine and nab-paclitaxel. The device called Optune Pax, is a portable, wearable system that uses low-intensity electric fields to disrupt cancer cell…
Boston-based Massachusetts General Hospital — part of Somerville, Mass.-based Mass General Brigham — has received $35 million from Irving Oil to fund two cancer-focused facilities within the Phillip and Susan Ragon Building, currently under construction. The funds will establish the…